Catalog No. | HF909036 |
---|---|
Species reactivity | Human |
Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
Host species | Human |
Isotype | IgG2-kappa |
Expression system | Mammalian Cells |
Species | Human |
Clonality | Monoclonal |
Target | Beta-nerve growth factor, NGFB, Beta-NGF, NGF |
Endotoxin level | Please contact with the lab for this information. |
Purity | >95% as determined by SDS-PAGE. |
Purification | Protein A/G purified from cell culture supernatant. |
Accession | P01138 |
Form | Liquid |
Storage buffer | 0.01M PBS, pH 7.4. |
Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternate Names | 4D4, AMG-403, JNJ-42160443, 902141-80-4 |
Background | Luvagrobart is an anti-NGF human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001). • Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment., PMID:21358750 • Nerve growth factor R221W responsible for insensitivity to pain is defectively processed and accumulates as proNGF., PMID:19038341 • Rare human nerve growth factor-β mutation reveals relationship between C-afferent density and acute pain evaluation., PMID:27146986 • Genomic NGFB variation and multiple sclerosis in a case control study., PMID:19063739 • A novel NGFB point mutation: a phenotype study of heterozygous patients., PMID:18420729 • Variation in the BDNF and NGFB genes in German atopic dermatitis patients., PMID:19038326 • Variation in NGFB is associated with primary affective disorders in women., PMID:21294249 • Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders., PMID:18203754 • In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V., PMID:19945432 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
SDS-PAGE for Research Grade Fulranumab.
+86-027-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China